MBRX - צמיחת מכירות ב-12 חודשים נגררים moleculin.com

לוגו גרפי של Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. (MBRX) creates unique molecules to combat tumor resistance, ensuring high margins. The company relies on contract manufacturing and outsourced trial management. The year-over-year sales trend over the last 12 months visualizes revenue dynamics, where 0.00 serves as the base parameter value. The business is resilient to macro cycles, expanding through the commercialization of innovations and clinical trial phases.

צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Moleculin Biotech, Inc. (MBRX): לתקופה 11.02.2024 - 18.11.2026

פילוחי נתונים אנליטיים מרוכזים עבור moleculin.com (MBRX)

- מחיר נוכחי ושווי מניות חזוי:
ניתוח כל מדדי החברה:MBRX - Moleculin Biotech
מוצר סדרתי של Moleculin Biotech, Inc.

Year-over-year (TTM) sales growth measures the percentage change in annual revenue over a rolling period in continuous dynamics. This metric is calculated as the difference between current aggregate income and the equivalent window from the previous year, reflecting the business's sensitivity to market demand. By analyzing the trajectory of YoY sales volume growth over a rolling year, an investor assesses commercialization efficiency. For Moleculin Biotech, Inc. (MBRX), this trend depends directly on the success of the Phase 2 trials for annamycin.